Home
Productsindex
Gene
BioActive Proteinsindex
BioActive Biomarker Proteinslists
BioActive Human BTK (C481S) Recombinant Protein,Fc Tag
SGRP00688
BioActive Human BTK (C481S) Recombinant Protein,Fc Tag
Source:Full length Human BRCA2 deletion, expressed in HEK293 cells.
SKU:SGRP00688-100UG
Product Name:BioActive Human BTK (C481S) Recombinant Protein,Fc Tag
Product Description:Human BTK with mutation C481S expressed in HEK293 cells with activity confimed by ELISA.
SKU:SGRP00688-100UG
Product Name:BioActive Human BTK (C481S) Recombinant Protein,Fc Tag
Product Description:Human BTK with mutation C481S expressed in HEK293 cells with activity confimed by ELISA.
PROPERTIES
Biological Activity:
Fully biologically active
Purity:
> 95% by SDS-PAGE & HPLC
Endotoxin Level:
< 1.0 EU per μg protein as determined by the LAL method
Expression System:
HEK293 Cells
Format:
Recombinant
Species:
Human
Applications:
Sandwich ELISA Functional Studies Mass Spectrometry SDS-PAGE HPLC
Form:
Lyophilized from sterile PBS, pH 7.71
Concentration:
N/A
Stability and Storage:
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
Reconstitution:
Reconstitute with Phosphate Buffered Saline.
Related Categories
BioActive Biomarker Proteins
Background

Gene Accession

Q06187

Gene Alias

Protein names Recommended name Tyrosine-protein kinase BTK EC number EC:2.7.10.2 (UniProtKB | ENZYME | Rhea) Alternative names Agammaglobulinemia tyrosine kinase (ATK) B-cell progenitor kinase (BPK) Bruton tyrosine kinase Gene names Name BTK Synonyms AGMX1, ATK, BPK

Background

Acalabrutinib (A) is a selective, second-generation irreversible Bruton's Tyrosine Kinase inhibitor (BTKi) that has shown outstanding clinical activity in chronic lymphocytic leukemia (CLL) and other hematologic malignancies. Acquired resistance to the first-generation BTKi, ibrutinib (I), is mediated most commonly by C481S mutations in BTK, which decrease binding affinity and change binding from irreversible to reversible.

RECOMMENDED PRODUCTS
BioActive Human ABL1 (V299L,T315A,F317L,F317V,F317I,F317C) Recombinant Protein,Fc Tag
ABL1

SGRP00624

BioActive Human ABL1 (V299L,T315A,F317L,F317V,F317I,F317C) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human ABL1 (T315A,F317L,F317V,F317I,F317C,V299L) Recombinant Protein,Fc Tag
ABL1

SGRP00628

BioActive Human ABL1 (T315A,F317L,F317V,F317I,F317C,V299L) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human AKT1 (Q79K,E17K) Recombinant Protein,Fc Tag
AKT1

SGRP00630

BioActive Human AKT1 (Q79K,E17K) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human AKT1 (H238Y) Recombinant Protein,Fc Tag
AKT1

SGRP00631

BioActive Human AKT1 (H238Y) Recombinant Protein,Fc Tag
View Price and Availability
BioActive Human ALK (G1123S) Recombinant Protein,Fc Tag
ALK

SGRP00637

BioActive Human ALK (G1123S) Recombinant Protein,Fc Tag
View Price and Availability
0.142161s